Bosh sahifaINCY • NASDAQ
add
Incyte
58,21 $
Seans yopilganidan keyin:(0,00%)0,00
58,21 $
Yopilgan:17-apr, 16:26:27 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
57,73 $
Kunlik diapazon
57,08 $ - 58,69 $
Yillik diapazon
50,35 $ - 83,94 $
Bozor kapitalizatsiyasi
11,27 mlrd USD
Oʻrtacha hajm
2,25 mln
Narx/foyda
375,74
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,18 mlrd | 16,32% |
Joriy xarajat | 486,80 mln | 15,92% |
Sof foyda | 201,21 mln | 0,07% |
Sof foyda marjasi | 17,07 | -13,96% |
Har bir ulushga tushum | 1,43 | 34,91% |
EBITDA | 325,32 mln | 42,55% |
Amaldagi soliq stavkasi | 35,86% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,16 mlrd | -40,97% |
Jami aktivlari | 5,44 mlrd | -19,73% |
Jami passivlari | 2,00 mlrd | 25,40% |
Umumiy kapital | 3,45 mlrd | — |
Tarqatilgan aksiyalar | 193,52 mln | — |
Narxi/balansdagi bahosi | 3,24 | — |
Aktivlardan daromad | 14,28% | — |
Kapitaldan daromad | 22,24% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 201,21 mln | 0,07% |
Operatsiyalardan naqd pul | 381,22 mln | 158,05% |
Sarmoyadan naqd pul | -21,46 mln | 86,11% |
Moliyadan naqd pul | 20,39 mln | 5 794,22% |
Naqd pulning sof oʻzgarishi | 383,60 mln | 2 894,73% |
Boʻsh pul | 358,98 mln | 61,70% |
Haqida
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Tashkil etilgan
2002
Sayt
Xodimlar soni
2 617
